e-FoodSafety.com (OTC BB: EFSF) - 500 Beiträge pro Seite

[admetos]

STOCKS TO WATCH

WKN: 590128 / Berlin

e-FoodSafety.com (OTC BB: EFSF)
Last sale: 47 cents

e-FoodSafety.com is the only company with a patent pending chemical and inspection process that can boast an entire system dedicated to protecting, certifying, and delivering food safe products that far exceed current Federal Drug Administration (FDA) requirements. We first brought EFSF to your attention last month at 39 cents. Since then, e-FoodSafety.com has issued the following announcements:

Thursday January 22, 2004: e-FoodSafety.com, Inc. Expected to Receive 50-Unit Order from Marketing & Distribution Supplier Tru-Pure Ozone Technologies, Inc. http://biz.yahoo.com/bw/040122/225189_1.html

Tuesday February 3, 2004: e-FoodSafety.com, Inc.`s Patent Pending `Food Safe` Process Compatible with Bush Administration`s $441 Million Funding for National Food Security http://biz.yahoo.com/bw/040203/35177_1.html

Tuesday February 17, 2004: e-FoodSafety.com, Inc.`s Patent Pending `Food Safe` Process Now Effective on Meat and Poultry http://biz.yahoo.com/bw/040217/175515_1.html

EFSF could present a "FIRST IN A COMMERCIAL SPACE" investment opportunity. FedEx, Microsoft and Yahoo! are examples of other "First in a Commercial Space" companies. A $5,000 investment in FedEx a month after becoming a public company would be worth $235,680 today. A $5,000 investment in Yahoo! and Microsoft a month after becoming public would be worth $169,200 and $1,326,180 respectively.

e-FoodSafety.com is projecting revenues of $35 million for 2004, $80 million for 2005 and $200 million for 2006. Net income projections are $1.5 million for 2004, $7 million for 2005 and $29 million for 2006.

Initial sales are targeted to come from among the 20 largest companies in the industry. PARENTHETICALLY, THESE ARE ALSO THE COMPANIES MOST LIKELY TO ACQUIRE EFSF.

Check out e-FoodSafety.com`s web site at http://www.e-foodsafety.com plus EFSF`s SEC filings. The potential here is enormous. Further announcements (expected soon) will ensure that e-FoodSafety.com keeps making news and constantly increasing market awareness should continue to drive the EFSF stock price very much higher short-term.

Vielleicht eine Betrachtung wert?

MFG

[thefrontbroker]

Eine Analyse zu EFSF ist unter folgendem Link abrufbar:

http://www.wallstreet-online.de/ws/go.php?to=efsf&m=26.7 .

EFSF hat auf jeden Fall ein spannendes Geschäftsmodell:
Eine komplette Prozessverarbeitungsstruktur, um sichere Lebensmittel in den Regalen der Supermärkte zu garantieren.

..."Das Unternehmen ist in seinem Nischenmarkt gut aufgestellt. Das Management von EFSF hat außergewöhnliche Kontakte zu Unternehmen und Regierungskreisen aufgebaut und zählt zu den erfahrensten Anbietern im Gebiet frisches Obst und Erzeugnisse. Es besitzt nicht nur die Fähigkeiten, die nötig sind, um das Unternehmenskonzept umzusetzen, sondern auch die notwendigen Fertigkeiten, um die internationale Expansion des Unternehmens aggressiv voranzutreiben. Durch seine bestehenden Kontakte auf unterschiedlichstem Niveau zu Regierung, Lebensmittelketten und dem Food Dienstleistungswesen genießt das Unternehmen eine beneidenswerte Position hinsichtlich sofortigen potenziellen Geschäftsaussichten. Diese Faktoren machen EFSF zusammen mit der führenden Technologie des Unternehmens, fehlenden gleichwertigen Wettbewerbern und einer starken Geschäftsstrategie zu einem interessanten Investment mit dem Potenzial für einen raschen Beginn sich fortlaufend verbessernder Erträge..."

..."Lebensmittellieferungen und -dienstleistungen sind ein 660 Mrd. Dollar Segment. Innerhalb dieses Segments sind organische Lebensmittel für 91 Mrd. Dollar des jährlichen Absatzes verantwortlich, was etwa 14% des gesamten Einzelhandelsabsatzes entspricht. Vor fünf Jahren umfasste das Segment für Services und Lieferung von Lebensmitteln ungefähr 585 Mrd. Dollar und implizierte, dass die gesamte Branche nur etwa 2-3% pro Jahr wuchs. Jedoch repräsentierten organische Lebensmittel vor fünf Jahren nur 2% der gesamten Branche. Die Übersetzung in eine jährliche Wachstumsrate zeigt, dass das kommerzielle Potenzial für organische Lebensmittel ein Wachstum von 50% p.a. aufgewiesen hat - eine ausserordentlich hohe Wachstumsrate für jedes Wirtschaftsbarometer und ein wichtiger Faktor, um den optimalen Marktwert für das Geschäftsmodell von EFSF zu bestimmen..."

[lifa]

Stock Pick of the Year for 2006

http://www.konlin.com/pdffiles/stockpick06.pdf

[lifa]

eFoodSafety.com Inc. Subsidiary Knock-Out Technologies Ltd. Files for Patent Protection on Bird Flu Formulas
Wednesday April 19, 9:45 am ET
Citroxin and Citroxin O2 Secure 'Patent Pending' Status for Formulations

SCOTTSDALE, Ariz.--(BUSINESS WIRE)--April 19, 2006--Patricia Gruden, president/CEO of eFoodSafety.com Inc. (OTCBB: EFSF - News), announced today that the company's wholly owned subsidiary, Knock-Out Technologies Ltd., has filed with the United States Patent and Trademark Office for patent protection on their bird flu formulations, Citroxin and Citroxin O2....

http://biz.yahoo.com/bw/060419/20060419005248.html?.v=1

[chrisbo.kol]

aktuell 0,35 USD -> +22%

StockTargets Inc.: Investor targets increase on eFoodSafety.com, Inc. stock (Pink Sheets: EFSF) following a recent analyst recommendation

May 24, 2006 (M2 PRESSWIRE via COMTEX) -- Geneva, Switzerland, and Dover, Delaware, USA - StockTargets, Inc., a private Swiss company and an innovator in investor sentiment tracking on listed stocks, measured a firm shift in investor targets over the past 2 days on eFoodSafety.com, Inc. (Pink Sheets: EFSF), following a new recommendation.

Investor sentiment and forecast shows a substantial increase, and remains resolutely positive on the stock's prospects, following the latest news and a revaluation of the company by TTS Zurich http://www.ttszurich.com. Investors now forecast the stock rising to approximately US$ 1.36 during the next 12 months. The StockTargets consensus 12 months target was US$ 1.02 recently. Based upon their recommendation, the share price has recently moved from US$ 0.24 to US$ 0.26.

The 12 months target by TTS Zurich for the stock is US$ 0.70. These different targets can be reviewed by clicking the following link: http://www.stocktargets.com/cgi-bin/ticker.pl?command=efsf.ob" target="_blank" rel="nofollow ugc noopener">http://www.stocktargets.com/cgi-bin/ticker.pl?command=efsf.ob Targets indicators on stock are an aggregate of all the news, sentiment and forecasts available on the company at a given moment in time, as perceived by investors. eFoodSafety.com, Inc. website is http://www.e-foodsafety.com.

eFoodSafety.com, Inc. is a fully-reporting company dedicated to improving food and health conditions around the world through innovative products and technologies. eFoodSafety has two (2) wholly-owned subsidiaries: Knock-Out Technologies, Ltd. and MedElite, Inc.

About StockTargets, Inc.

StockTargets, Inc. (http://www.stocktargets.com) is an investment banking and investor relations firm. Its Web site records all participants' sentiment, expressed as targets by its users. The StockTargets system, by building an investor sentiment indicator, attempts to gather and determine an measurement of all entries of users. The user's consensus target can be compared to targets provided by professionals, such as brokerage firms, analysts or fund managers. StockTargets Inc. was founded in 2005.

This press release contains forward-looking statements within the meaning of section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. With the exception of historical information contained herein, the matters discussed in this press release involve risk and uncertainties. Actual results could differ materially from those expressed in any forward-looking statement. All trademarks mentioned in this text are properties of their respective owners.

CONTACT: Sean Kelly, StockTargets Inc. Tel: [phone]

M2 Communications Ltd disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web Inquiries to [e-mail].


(C)1994-2006 M2 COMMUNICATIONS LTD

[wonner]

Antwort auf Beitrag Nr.: 21.799.018 von chrisbo.kol am 25.05.06 18:33:28

hier mal eine kleine neuigkeit,da muß man erstmal hinkommen!
wollen doch mal sehen wie weit es diesmal trägt !!!

SCOTTSDALE, Ariz.--(BUSINESS WIRE)--July 5, 2006--Patricia Gruden, President/CEO of eFoodSafety.com, Inc. (OTCBB: EFSF), announced today the opportunity for the Company to ultimately test its Citroxin formulation on the Bird Flu virus on live subjects in Thailand after protocol testing of a wide range of infectious diseases. The Company's Citroxin formulation was hand-delivered by a Company representative to the National Center for Genetic Engineering and Biotechnology (BIOTEC), a branch of the National Science and Technology Development Agency (NSTDA) located in the greater Bangkok metropolitan area.

The NSTDA was established in 1991 by the Royal Government of Thailand and officially commenced its operation in 1992. The establishment of NSTDA, unlike other public science and technology organizations in Thailand, was unique as it was aimed to "be the Agency with a high degree of autonomy and mobility unbound by the normal rules, procedures, and regulations of governmental bureaucracy" in order to "conduct, support, coordinate, and promote efforts in scientific and technological development between the public and private sectors towards maximal benefit for national development." Since its establishment, NSTDA has served as the hub where leading scientists and experts meet and work to tackle scientific and technological issues of imminent concern to both national and international communities.

The significance of testing in a region that has been affected by the bird flu virus will allow for the opportunity for the Company's Citroxin formula ultimately to be tested, after background protocol testing on other infectious diseases, on live subjects.

"It was recent favorable testing results of our Citroxin formulation on the bird flu in the United States that has brought about the opportunity to test abroad at one of Thailand's most prestigious agencies, the NSTDA. To have the opportunity to test the Citroxin formulation on live subjects in a region with conclusive evidence confirming the existence of the bird flu virus in animals and humans is very significant," stated Mrs. Gruden.

[chrisbo.kol]

Antwort auf Beitrag Nr.: 22.422.178 von wonner am 05.07.06 17:37:14

hört sich ja ganz gut an! aktuell 0,29 d.h. +23,4%
im RB gibts auch schon ein update des Konlin-Letters:

"EFSF is a pioneering company with stunning breakthrough
technology on the verge of explosive revenue growth. EFSF is
dedicated to improving health conditions around the world through
its proprietary innovative technologies with products entering multibillion
dollar markets. EFSF believes it has formulated the “Total
Solution” to the potential Avian Influenza (Bird Flu) pandemic.

Its Knock-Out Technologies, Ltd. subsidiary has developed a revolutionary,
environmentally safe sporocidal product formulated entirely
of food-grade components that eradicates the most lethal of all
biological weapons, Anthrax, and a germicidal product Citroxin (EPA
REG#82723-1) that kills six major bacteria: E-coli, Listeria, Pseudomonas,
Salmonella, Staphylococcus, Streptococcus, and is 100% effective at
wiping out Black Mold (stachybotrys chartarum), which is overrunning
hurricane-ravaged areas in the Gulf Coast. Most important, it could
become the anti-viral prophylaxis (applying the remedy before the
cure), the total solution of choice for the deadly Bird Flu.

EFSF’s MedElite, Inc. subsidiary distributes clinically proven
products to physicians who then prescribe them to their patients. It
is the exclusive worldwide and U.S. distributor of the Talsyn™-Ci/bid
Scar Cream that has been clinically proven to facilitate and improve
the appearance, redness, and strength of scars. It is one of the most
efficacious scar creams on the market today, entering a $4 bil. market.

The potential is huge. EFSF is also a distributor for Cinnergen™, a nonprescription
liquid whole food nutritional supplement that promotes
healthy glucose metabolism and Trimmendous™, a weight loss
formula focusing on the body’s 24-hr. metabolic processes.
Health professionals have been aware of the adverse health effects
of exposure to mold for decades. Studies indicate that 50% of all homes
contain certain molds and the dramatic increase in asthma over the
past 20-yrs. can be attributed to mold exposure. Toxic mold can form
on most building surfaces and products (dry wall, insulation, ceiling
tiles, carpet, etc.) if it remains wet for 24-48 hours. Citroxin Cleaner can
significantly reduce costs of the rapidly growing new sector of the
environmental remediation industry—toxic mold.

EFSF continues its massive Direct Response Marketing Campaign
via radio and TV for its Cinnergen™ Diabetes product (a $132 bil.
market). Diabetes is becoming one of the fastest growing chronic
health problems in America’s aging population. Cinnergen™ encapsulates
a proven effective naturally occurring compound found in
cinnamon that can supplement subscription diabetes medications
(Type 1 diabetic patients) and help decrease medication needs in Type
2 diabetic and borderline patients. Sales have exceeded expectations
with their marques of companies including, General Nutrition Centers
(GNC-over 5,000 related locations worldwide), The Vitamin Shoppe
(over 260 retail locations in the U.S.), Kinray, Inc., the largest privately
held distributor of pharmaceutical, generic and health and beauty care
products in the world (sales in excess of $3.5 annually), The F. Dohmen
Co., a wholesale distributor serving the pharmacy industry for over 140
years and Smith Drug Co. (division of J.M Smith Corp., 6th largest
privately held company) serving over 1,000 pharmacies in the midsoutheast
U.S.

In less than a year of a major restructuring, EFSF has generated
sales for the 1st 9 mos. FY’06 of $116,008, with a loss per share of (.04).
EFSF anticipates to be profitable for Q1’06 on an operational basis
with sales exceeding all of FY’05. The company has virtually no debt
and of the 128,674,000 shares outstanding, approx. 60% are held
by insiders. The stock, testing support since Sept. '05, successfully
achieved higher lows. It is on the verge of completing a short-term
double bottom for the launching of its next up-leg. The huge short
position is the fuel to drive it to our 1st target of 2.00, but it must first
close above .8750.

This ground floor opportunity with explosive
growth potential has already established positive fundamentals, and
has more products in the pipeline (some already generating revenue)
that could see sales growth of $8 mil. in the next 10 mos., especially as
it enters into a multi-million-dollar worldwide direct marketing
campaign to sell its anti-acne product with a high-profile celebrity
spokesperson. Worldwide appeal for the product could easily approach
$200mil.as the leading competitor’s sales exceeded $300 mil. last year.

EFSF has entered the biotech arena with its revolutionary Lyme’s
Disease product; human clinical trials are currently underway with
EFSF’s safe, natural, ingestible product that is believed to offer a
positive treatment for chronic Lyme’s Disease. In ’03, the National
Center of Infectious Diseases estimated annual cost for treatment of
disease at $60 mil. a year in the U.S. EFSF is also on the verge of entering
the $33 bil. domestic market of obesity to sell Trimmendous™, an
all-natural (effedrine-free) weight loss formula that has unique
selling and performance benefits that could readily capture significant
market share. Our original target has been $4-$6, but with products
coming on line better than anticipated with positive lab results, along
with EFSF’s total solution to the Bird Flu, and with live testing about
to begin, the stock could soar.

Yes, I own the stock and believe in both
the company and its management"

[chrisbo.kol]

Antwort auf Beitrag Nr.: 22.422.178 von wonner am 05.07.06 17:37:14

nach dem letzten break-out ist der kurs rasch wieder zurückgekommen, aber erneut ausbruch (aktuell 18% auf 0,29 us-cents)auf grund der heutigen NEWS, in denen der follow -up report des konlin - letters juli 2006 und die darin prognostizierten fantastischen aussichten für EFSF angeführt werden.
bin ja mal gespannt, ob sich diesmal eine basis auf höherem kursniveau ausbilden kann.

SCOTTSDALE, Ariz., Jul 11, 2006 (BUSINESS WIRE) -- Patricia Ross-Gruden, president and CEO of eFoodSafety.com Inc. ( EFSF ), announced today that The KonLin Letter issued a Follow-Up Report on eFoodSafety.com Inc. in its July 2006 issue. The KonLin Letter reiterates its "Strong Buy" recommendation of EFSF stock.

According to Konrad Kuhn, editor of The KonLin Letter, Patricia Gruden has done a masterful job of repositioning the company and setting the stage for eFoodSafety.com Inc. to become a dominant player in the scar cream and diabetes markets, while bringing the company to the forefront with potential solutions in both the Lyme disease and bird flu arenas.

The KonLin Letter, a 25-year-old investment advisory newsletter noted for its fundamental and technical analysis of individual stocks and market movements, does not accept compensation for its analyses of selected companies. The report includes a review of the latest developments of the company, the company's market position and potential advantages, along with fundamentals and statistics.

Kuhn cited the following reasons for his July 2006 follow-up recommendation:

-- First quarter revenue for 2006-2007 should exceed the total revenue for all of the four quarters in Fiscal Year 2005-2006.

-- The bird flu formulation currently is in patent pending status and could be entering a multibillion-dollar market shortly. More news is anticipated on this product. Indications are that additional testing is ongoing.

-- The sales of Cinnergen(TM) from both its Direct Response Marketing Campaign and retail sales are exceeding initial expectations.

-- The Lyme's formulation is undergoing human clinical trials and initial results indicate it could become the only treatment known to treat long-term chronic Lyme disease.

-- In fiscal year 2006-2007, the anti-acne product sales are expected to commence with long-term sales estimated in the $200 million range. It is anticipated that a high-profile celebrity and brand name will be announced soon.

"I've said it before and I'll say it again, never before have I seen a company with such huge upside potential in so many multibillion-dollar arenas, in my 25-year history as a newsletter writer," stated Kuhn.

About KonLin Research & Analysis Corp.

The KonLin Letter, www.KonLin.com, chooses low-priced stocks to analyze, with an emphasis on emerging growth and special situations poised for explosive price appreciation. The KonLin Letter has constantly been one of the leading publications on Wall Street. It has been rated one of the best-performing market letters in the nation, offering a unique service that each month recommends five low-priced selections, including a featured stock of the month. EFSF was the featured stock in the month of September 2005.

About eFoodSafety.com Inc.

eFoodSafety.com Inc. is dedicated to improving health conditions around the world through its innovative technologies. The company's Knock-Out Technologies Ltd. subsidiary has developed an environmentally safe sporicidal product formulated entirely of food-grade components that eradicates anthrax and a germicidal product, Big 6 Plus - EPA Reg. No. 82723-1 that kills six major bacteria: E-coli, Listeria, Pseudomonas, Salmonella, Staphylococcus, and Streptococcus, Avian Influenza, and Black Mold. The sporicidal product has completed its final efficacy laboratory study requisite for EPA registration. In the study, it eradicated both Clostridium Sporogenes and Bacillus Subtilis with 100% efficacy on both hard and porous surfaces. The company's MedElite Inc. subsidiary distributes clinically proven products to physicians who then prescribe the products for their patients. It is the exclusive U.S. and worldwide distributor of the Talsyn(TM)-CI/bid Scar Cream that has been clinically proven to facilitate and improve the appearance, redness and strength of scars ( www.talsyn.com). The company is also is a distributor for Cinnergen(TM), a nonprescription liquid whole food nutritional supplement that promotes healthy glucose metabolism ( www.cinnergen.com), and Trimmendous(TM), a weight loss formula focusing on the body's 24-hour metabolic processes. The company has recently entered into a joint venture agreement with CK41 Direct Inc. to launch an anti-acne skin care system, with a branded name and celebrity spokesperson to be announced in the near future.

Please visit the company's Web site at http://www.efoodsafety.com.

Safe Harbor Forward-Looking Statements

Statements contained in this release that are not strictly historical are "forward-looking" statements within the meaning of Section 27A of the Securities Act of 1933 as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The forward-looking statements are made based on information available as of the date hereof, and the company assumes no obligation to update such forward-looking statements. Editors and investors are cautioned that such forward-looking statements involve risks and uncertainties and the company's actual results may differ from these forward-looking statements. Such risks and uncertainties include but are not limited to demand for the company's products and services, our ability to continue to develop markets, general economic conditions, our ability to secure additional financing for the company and other factors that may be more fully described in reports to shareholders and periodic filings with the Securities and Exchange Commission.

SOURCE: eFoodSafety.com Inc.

Redwood Consultants, LLC
Jens Dalsgaard, 415-884-0348


Copyright Business Wire 2006

[wonner]

also ich hühner schon zwei jahre mit der aktie rum.
wenn das alles kein bluff ist, wovon ich ausgehe, würde ich sagen das die aktie eigentlich irgendwann platzen müßte, im positiven.
wen die test gegen vogelgrippe in thailand erfolgreich sind, muß das ja eigentlich ein verkaufsschlager weltweit werden. also viel geld.
aber die aktie dümpelt so vor sich hin.
jedenfalls gehören diese enormen kursausschläge der vergangenheit an.
langsam stetiges steigen wäre mir lieber.
na dann mal los !!!

[chrisbo.kol]

na, wer sagt`s denn hält sich doch ganz wacker !!

[chrisbo.kol]

hier nochmals die äußerst bemerkenswerte passage über EFSF aus dem follow-up report des konlin-letters vom juli 2006 !!

"I\'ve said it before and I\'ll say it again, never before have I seen a company with such huge upside potential in so many multibillion-dollar arenas, in my 25-year history as a newsletter writer," stated Kuhn.

[wonner]

na dann lass uns mal schauen ob der mann weiß was er sagt.

[chrisbo.kol]

Antwort auf Beitrag Nr.: 22.545.792 von wonner am 12.07.06 16:55:07

wollen wir`s hoffen
mal wieder ne heftige achterbahnfahrt - aber wenn`s zum schluß immer wieder nach oben geht hab ich auch nix dagegen !

[wonner]

Antwort auf Beitrag Nr.: 22.546.793 von chrisbo.kol am 12.07.06 17:57:32

klappert ja ganz gut die frau ross gruden.


SCOTTSDALE, Ariz.--(BUSINESS WIRE)--July 13, 2006--Patricia Ross-Gruden, president and CEO of eFoodSafety.com Inc. (OTCBB: EFSF), announced today that eFoodSafety.com Inc. confirms reports that the bird flu virus has spread from human to human.

A report from Indonesia stated that a woman contracted the H5N1 virus, spread it to her 10-year-old son, and five other blood relatives. All but one who contracted the virus had died.

On Nov. 7, 2005, Lee Jong-Wook, leader of the World Health Organization (WHO), stated, "It is only a matter of time before an avian-flu virus -- most likely H5N1 -- acquires the ability to be transmitted from human to human, sparking the outbreak of human pandemic influenza. We don't know when this will happen. But we do know that it will happen."

The recent findings in Indonesia provide proof that the bird flu virus has now inevitably begun to spread between humans.

In the June 24, 2006, edition of the Washington Times, United Nations Bird Flu Chief David Nabarro said this is a "vivid reminder of the need to keep a very close watch on what the virus is doing." A pandemic of bird flu would be an unprecedented disaster. Economically, the World Bank warned that a bird flu pandemic could cause global gross domestic product to drop by 2 percent -- or about $800 billion a year. It is difficult to estimate a reasonable death count, but WHO forecasts have consistently remained at 2 million to 7.4 million deaths worldwide."

Ongoing testing of eFoodSafety.com Inc.'s bird flu formulation -- Citroxin -- is currently under way in this Far Eastern region. Gruden commented, "We specifically began testing in Thailand to be as close as possible to the 'hot spot' where this potential pandemic could break out."

[chrisbo.kol]

Antwort auf Beitrag Nr.: 22.569.978 von wonner am 13.07.06 17:17:52

schon seit 3 tagen im plus - ist das endlich mal der durchbruch???

...übrigens, schau dir mal PAIM an, da geht seit gestern der punk ab